Rapid Therapeutic Science Laboratories to Attend the Respiratory Drug Delivery (RDD) 2022 Conference
April 28, 2022 07:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, April 28, 2022 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented aerosol manufacturing company focused on...
Outlook on the Digital Dose Inhaler Global Market to 2026 - by Type, Product and Region
November 24, 2021 08:23 ET
|
Research and Markets
Dublin, Nov. 24, 2021 (GLOBE NEWSWIRE) -- The "Digital Dose Inhaler Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Worldwide Inhalers & Nebulizers Industry to 2026 - Technological Advancements in Smart Inhaler Devices and Systems Presents Opportunities
November 04, 2021 08:53 ET
|
Research and Markets
Dublin, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The "Inhalers & Nebulizers Market Research Report by Product, Indication, Distribution Mode, and Region - Global Forecast to 2026 - Cumulative Impact of...
Rapid Therapeutic Prepares to file Investigational New Drug Application for its CBD Metered Dose Inhaler with FDA
June 02, 2021 07:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, June 02, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of...
Worldwide Smart Inhalers Industry to 2025 - Rising Prevalence of Respiratory-Related Disorders is Driving Growth
April 21, 2021 06:13 ET
|
Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Global Smart Inhalers Market (2020-2025) by Components, Product, Application, Distribution Channel, End-Use, Geography, Competitive Analysis and the...
Rapid Therapeutic Hires Pharmaceutical Industry Authority to Oversee Labs
January 26, 2021 07:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on employing...
Outlook on the Respiratory Inhaler Devices Global Market to 2025 - Impact of COVID-19 with Ansoff Analysis
December 21, 2020 04:48 ET
|
Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Global Respiratory Inhaler Devices Market (2020-2025) by Product, Technology, End-User, Disease Indication and Geography and the Impact of Covid-19...
Rapid Therapeutic Selects Clinical Research Center to Start Clinical Trials Using its Proprietary CBD and CBG Formulation
December 03, 2020 07:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
Rapid Therapeutic Completes $14 Million Acquisition of Razor Jacket
December 01, 2020 07:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
Worldwide Industry for Aerosol Delivery Devices to 2027 - Increase in Prevalence of COPD and Asthma is Driving Growth
October 16, 2020 05:28 ET
|
Research and Markets
Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Aerosol Delivery Devices Market by Product, Application and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report...